J. David Joyner
CIK: 0001515598
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CVS HEALTH Corp
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Apr 1, 2026CVS
CVS HEALTH Corp
Tax Payment(F)Direct8K shares at avg. $72.49$582K - Mar 31, 2026CVS
CVS HEALTH Corp
Award(A)Direct86.3K shares at avg. $71.82$6.2M - Feb 28, 2026CVS
CVS HEALTH Corp
Tax Payment(F)Direct1.9K shares at avg. $79.90$155K - Apr 1, 2025CVS
CVS HEALTH Corp
Award(A)Direct53.3K shares- - Apr 1, 2025CVS
CVS HEALTH Corp
Tax Payment(F)Direct1.8K shares at avg. $67.98$126K - Apr 1, 2025CVS
CVS HEALTH Corp
Award(A)DirectStock Option
226.1K shares at avg. $67.98- - Feb 28, 2025CVS
CVS HEALTH Corp
Tax Payment(F)Direct1.9K shares at avg. $65.72$128K - Nov 30, 2024CVS
CVS HEALTH Corp
Award(A)DirectPremium Stock Option
1M shares at avg. $71.82- - Nov 30, 2024CVS
CVS HEALTH Corp
Award(A)DirectPremium Stock Appreciation Right
492.5K shares at avg. $71.82- - Nov 30, 2024CVS
CVS HEALTH Corp
Award(A)DirectPremium Stock Option
1.5M shares at avg. $71.82-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | CVS CVS HEALTH Corp | Tax Payment(F) | 8,029 | $72.49 | $582,022 | Direct |
| Mar 31, 2026 | CVS CVS HEALTH Corp | Award(A) | 86,326 | $71.82 | $6,199,933 | Direct |
| Feb 28, 2026 | CVS CVS HEALTH Corp | Tax Payment(F) | 1,944 | $79.90 | $155,326 | Direct |
| Apr 1, 2025 | CVS CVS HEALTH Corp | Award(A) | 53,324 | - | - | Direct |
| Apr 1, 2025 | CVS CVS HEALTH Corp | Tax Payment(F) | 1,847 | $67.98 | $125,559 | Direct |
| Apr 1, 2025 | CVS CVS HEALTH Corp | Award(A) Stock Option | 226,138 | $67.98 | - | Direct |
| Feb 28, 2025 | CVS CVS HEALTH Corp | Tax Payment(F) | 1,944 | $65.72 | $127,760 | Direct |
| Nov 30, 2024 | CVS CVS HEALTH Corp | Award(A) Premium Stock Option | 1,000,000 | $71.82 | - | Direct |
| Nov 30, 2024 | CVS CVS HEALTH Corp | Award(A) Premium Stock Appreciation Right | 492,537 | $71.82 | - | Direct |
| Nov 30, 2024 | CVS CVS HEALTH Corp | Award(A) Premium Stock Option | 1,492,537 | $71.82 | - | Direct |
1-10 of 10 transactions
About Joyner J. David
Joyner J. David (SEC CIK 0001515598) files insider reports with the SEC as President, CEO and Chair of CVS HEALTH Corp (CVS).
Signal8 holds 7 ownership filings by Joyner J. David, all Form 4s, filed between Dec 3, 2024 and Apr 2, 2026. Those filings report 10 transactions, from Nov 30, 2024 to Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Joyner J. David's filings is in WOONSOCKET, RI.
Recent filings by Joyner J. David
- Apr 1, 2026: Tax withholding of CVS shares (Form 4, code F).
- Mar 31, 2026: Grant or award of CVS shares (Form 4, code A).
- Feb 28, 2026: Tax withholding of CVS shares (Form 4, code F).
- Apr 1, 2025: Grant or award of CVS shares (Form 4, code A).
- Apr 1, 2025: Tax withholding of CVS shares (Form 4, code F).
Other insiders filing for CVS HEALTH Corp (CVS)
- Clark James David, SVP, Cont & Chief Acct Officer
- Newman Brian, EVP, Chief Financial Officer
- Compton-Phillips Amy, EVP, Chief Medical Officer
- AGUIRRE FERNANDO, Director
- ROBBINS LARRY, Director
- Gallina John E, Director